The present study is the first to report the prognostic relevance of ZEB1 expression in IPMN, and supports the hypothesis that treatment strategies targeting ZEB1 may also target tumor cells, as well as stromal cells. This evidence concerns the gene ZEB1 and pancreatic intraductal papillary-mucinous neoplasm.